2026 Q1 -tulosraportti
Vain PDF
91 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·18 t sittenAnxious about the financial report, whether to stay or flee. I think it's steadily leaking away all the time.
I primarily believe that the stock is at this level because many are holding onto their shares, and there is clearly someone to buy them all up in the range 0.9-1.1 kr,- And the board has also bought in themselves at the beginning of the year, around price 1.4 kr,- so there is a sign that they (henrik elbæk) expect the price to go significantly above that level in the future.
·20 t sittenStock status Canngo: has sold out at two pharmacies, has gone from 6 to 4 pharmacies Weed.de: has sold out at an additional 1 pharmacy. they have gone from 7 pharmacies to 3 pharmacies. None of the pharmacies that have been sold out since last Thursday, July 29th, have received Weeco Astrum 10/10 in stock yet. Bonus information. I have noticed that the other brands of cannabis oil have also started to be sold out, and these have not come into stock either. Based on this observation, I have started to lean towards the idea that it is sold out due to bottlenecks in delivery, and not because people have stopped buying Weeco Astrum 10/10- ·1 päivä sittenI have found an article confirming that standardized oils, such as Weeco Astrum 10/10, retain the subsidy, but now there is apparently doubt as to whether these oils have a quarantine period or not, because they write that only approved oils do not have a quarantine period. When they write approved oils, there are only 4-5 types, I can't remember how many, but Weeco Astrum 10/10 is not one of them. (it's complicated, so I won't start explaining how it works) This is yet another example that we have been left at the station, groping in the dark, because we haven't received anything concrete from the management; they have just remained silent. https://can-doc.de/blogs/news/gkv-cannabis-was-das-neue-spargesetz-fur-patienten-bedeutet
- ·1 päivä sittenSomeone asked about this news, I can't find you again so I'm putting it in here. Important changes in the pharmaceutical sector - the law on the stabilization of the statutory health insurance contribution rate comes into force on July 30, 2026. https://www.kvhh.net/de/praxis/verordnung/verordnung/wichtige-aenderungen-im-arzneimittelbereich-das-gkv-beitragssatzstabilisierungsgesetz-tritt-am-30-juli-2026-in-kraft.htmlyes but I can't take credit for it, someone else found it, I just took the link and put it in here. By the way, I have found out that there is a word for the frustrations I have expressed earlier regarding Stenocare's management being silent as the grave. Because we find news about this and that, which possibly, can have an impact on the share price such as this one. Instead of the long explanations, I could just write that we are trading blind. sigh. Explanation for those of you who haven't heard of this concept either. In the financial world, it is called shareholders trading blind. In this context, it means that we as investors are effectively kept in the dark and forced to navigate without the necessary data. When management does not provide proactive, clear, and timely communication about the company's progress or decline. A company must ensure that all shareholders receive the same information at the same time, and if they don't, it is said that shareholders are trading blind. E.g., to spell it out. If a shareholder sells the share based on outdated information, because management has not told the market that an upward adjustment is coming, then this person may have missed out on a gain. Likewise, if a person buys a share based on outdated data, and the company subsequently issues a message about a downward adjustment that has come too late in relation to the disclosure obligation, then this person may also lose money. if something leaks out to unsuspecting people who trade on this inside knowledge, then it harms those who have not received this knowledge. I believe that we are fumbling in the dark, with this share, people are selling and buying on outdated data. It is solely the management's responsibility, because they are silent as the grave. https://www.finanstilsynet.dk/finansielle-temaer/kapitalmarked/markedsmisbrugsforordningen/intern-viden
- ·1 päivä sittenStock status It is still sold out. Normally, I would refrain from writing anything when everything is status quo, but I do not believe it is a normal situation when, in the news that emerged earlier today, we can read that the subsidy for flower medicine has stopped as of last Friday, which is much earlier than initially announced; it was supposed to be from January 1, 2027. Furthermore, the article also stated that oil that is standardized (just like Weeco Astrum 10/10) is not affected by the quarantine. When Weeco Astrum 10/10 is not affected by the 6-month quarantine and the subsidy for flower medicine has stopped, I cannot help but speculate that pharmacies are sold out because there are bottlenecks with delivery, as it is still a stock item at the pharmacies that still have it in stock. To my knowledge, nothing has been released from Stenocare, so therefore it is speculation on my part, and I cannot say anything concrete; only the management from Stenocare can do that.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
91 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·18 t sittenAnxious about the financial report, whether to stay or flee. I think it's steadily leaking away all the time.I primarily believe that the stock is at this level because many are holding onto their shares, and there is clearly someone to buy them all up in the range 0.9-1.1 kr,- And the board has also bought in themselves at the beginning of the year, around price 1.4 kr,- so there is a sign that they (henrik elbæk) expect the price to go significantly above that level in the future.
- ·20 t sittenStock status Canngo: has sold out at two pharmacies, has gone from 6 to 4 pharmacies Weed.de: has sold out at an additional 1 pharmacy. they have gone from 7 pharmacies to 3 pharmacies. None of the pharmacies that have been sold out since last Thursday, July 29th, have received Weeco Astrum 10/10 in stock yet. Bonus information. I have noticed that the other brands of cannabis oil have also started to be sold out, and these have not come into stock either. Based on this observation, I have started to lean towards the idea that it is sold out due to bottlenecks in delivery, and not because people have stopped buying Weeco Astrum 10/10
- ·1 päivä sittenI have found an article confirming that standardized oils, such as Weeco Astrum 10/10, retain the subsidy, but now there is apparently doubt as to whether these oils have a quarantine period or not, because they write that only approved oils do not have a quarantine period. When they write approved oils, there are only 4-5 types, I can't remember how many, but Weeco Astrum 10/10 is not one of them. (it's complicated, so I won't start explaining how it works) This is yet another example that we have been left at the station, groping in the dark, because we haven't received anything concrete from the management; they have just remained silent. https://can-doc.de/blogs/news/gkv-cannabis-was-das-neue-spargesetz-fur-patienten-bedeutet
- ·1 päivä sittenSomeone asked about this news, I can't find you again so I'm putting it in here. Important changes in the pharmaceutical sector - the law on the stabilization of the statutory health insurance contribution rate comes into force on July 30, 2026. https://www.kvhh.net/de/praxis/verordnung/verordnung/wichtige-aenderungen-im-arzneimittelbereich-das-gkv-beitragssatzstabilisierungsgesetz-tritt-am-30-juli-2026-in-kraft.htmlyes but I can't take credit for it, someone else found it, I just took the link and put it in here. By the way, I have found out that there is a word for the frustrations I have expressed earlier regarding Stenocare's management being silent as the grave. Because we find news about this and that, which possibly, can have an impact on the share price such as this one. Instead of the long explanations, I could just write that we are trading blind. sigh. Explanation for those of you who haven't heard of this concept either. In the financial world, it is called shareholders trading blind. In this context, it means that we as investors are effectively kept in the dark and forced to navigate without the necessary data. When management does not provide proactive, clear, and timely communication about the company's progress or decline. A company must ensure that all shareholders receive the same information at the same time, and if they don't, it is said that shareholders are trading blind. E.g., to spell it out. If a shareholder sells the share based on outdated information, because management has not told the market that an upward adjustment is coming, then this person may have missed out on a gain. Likewise, if a person buys a share based on outdated data, and the company subsequently issues a message about a downward adjustment that has come too late in relation to the disclosure obligation, then this person may also lose money. if something leaks out to unsuspecting people who trade on this inside knowledge, then it harms those who have not received this knowledge. I believe that we are fumbling in the dark, with this share, people are selling and buying on outdated data. It is solely the management's responsibility, because they are silent as the grave. https://www.finanstilsynet.dk/finansielle-temaer/kapitalmarked/markedsmisbrugsforordningen/intern-viden
- ·1 päivä sittenStock status It is still sold out. Normally, I would refrain from writing anything when everything is status quo, but I do not believe it is a normal situation when, in the news that emerged earlier today, we can read that the subsidy for flower medicine has stopped as of last Friday, which is much earlier than initially announced; it was supposed to be from January 1, 2027. Furthermore, the article also stated that oil that is standardized (just like Weeco Astrum 10/10) is not affected by the quarantine. When Weeco Astrum 10/10 is not affected by the 6-month quarantine and the subsidy for flower medicine has stopped, I cannot help but speculate that pharmacies are sold out because there are bottlenecks with delivery, as it is still a stock item at the pharmacies that still have it in stock. To my knowledge, nothing has been released from Stenocare, so therefore it is speculation on my part, and I cannot say anything concrete; only the management from Stenocare can do that.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
91 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·18 t sittenAnxious about the financial report, whether to stay or flee. I think it's steadily leaking away all the time.I primarily believe that the stock is at this level because many are holding onto their shares, and there is clearly someone to buy them all up in the range 0.9-1.1 kr,- And the board has also bought in themselves at the beginning of the year, around price 1.4 kr,- so there is a sign that they (henrik elbæk) expect the price to go significantly above that level in the future.
- ·20 t sittenStock status Canngo: has sold out at two pharmacies, has gone from 6 to 4 pharmacies Weed.de: has sold out at an additional 1 pharmacy. they have gone from 7 pharmacies to 3 pharmacies. None of the pharmacies that have been sold out since last Thursday, July 29th, have received Weeco Astrum 10/10 in stock yet. Bonus information. I have noticed that the other brands of cannabis oil have also started to be sold out, and these have not come into stock either. Based on this observation, I have started to lean towards the idea that it is sold out due to bottlenecks in delivery, and not because people have stopped buying Weeco Astrum 10/10
- ·1 päivä sittenI have found an article confirming that standardized oils, such as Weeco Astrum 10/10, retain the subsidy, but now there is apparently doubt as to whether these oils have a quarantine period or not, because they write that only approved oils do not have a quarantine period. When they write approved oils, there are only 4-5 types, I can't remember how many, but Weeco Astrum 10/10 is not one of them. (it's complicated, so I won't start explaining how it works) This is yet another example that we have been left at the station, groping in the dark, because we haven't received anything concrete from the management; they have just remained silent. https://can-doc.de/blogs/news/gkv-cannabis-was-das-neue-spargesetz-fur-patienten-bedeutet
- ·1 päivä sittenSomeone asked about this news, I can't find you again so I'm putting it in here. Important changes in the pharmaceutical sector - the law on the stabilization of the statutory health insurance contribution rate comes into force on July 30, 2026. https://www.kvhh.net/de/praxis/verordnung/verordnung/wichtige-aenderungen-im-arzneimittelbereich-das-gkv-beitragssatzstabilisierungsgesetz-tritt-am-30-juli-2026-in-kraft.htmlyes but I can't take credit for it, someone else found it, I just took the link and put it in here. By the way, I have found out that there is a word for the frustrations I have expressed earlier regarding Stenocare's management being silent as the grave. Because we find news about this and that, which possibly, can have an impact on the share price such as this one. Instead of the long explanations, I could just write that we are trading blind. sigh. Explanation for those of you who haven't heard of this concept either. In the financial world, it is called shareholders trading blind. In this context, it means that we as investors are effectively kept in the dark and forced to navigate without the necessary data. When management does not provide proactive, clear, and timely communication about the company's progress or decline. A company must ensure that all shareholders receive the same information at the same time, and if they don't, it is said that shareholders are trading blind. E.g., to spell it out. If a shareholder sells the share based on outdated information, because management has not told the market that an upward adjustment is coming, then this person may have missed out on a gain. Likewise, if a person buys a share based on outdated data, and the company subsequently issues a message about a downward adjustment that has come too late in relation to the disclosure obligation, then this person may also lose money. if something leaks out to unsuspecting people who trade on this inside knowledge, then it harms those who have not received this knowledge. I believe that we are fumbling in the dark, with this share, people are selling and buying on outdated data. It is solely the management's responsibility, because they are silent as the grave. https://www.finanstilsynet.dk/finansielle-temaer/kapitalmarked/markedsmisbrugsforordningen/intern-viden
- ·1 päivä sittenStock status It is still sold out. Normally, I would refrain from writing anything when everything is status quo, but I do not believe it is a normal situation when, in the news that emerged earlier today, we can read that the subsidy for flower medicine has stopped as of last Friday, which is much earlier than initially announced; it was supposed to be from January 1, 2027. Furthermore, the article also stated that oil that is standardized (just like Weeco Astrum 10/10) is not affected by the quarantine. When Weeco Astrum 10/10 is not affected by the 6-month quarantine and the subsidy for flower medicine has stopped, I cannot help but speculate that pharmacies are sold out because there are bottlenecks with delivery, as it is still a stock item at the pharmacies that still have it in stock. To my knowledge, nothing has been released from Stenocare, so therefore it is speculation on my part, and I cannot say anything concrete; only the management from Stenocare can do that.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt